Bruker to acquire in-vitro diagnostics company ELITechGroup for €870m
Bruker Corporation (Nasdaq: BRKR) has solidified its position in the global life-science and diagnostics market through a definitive share purchase agreement to acquire ELITechGroup from TecFin S.à r.l., a controlled affiliate of PAI Partners, a leading private equity firm. The acquisition, valued at €870 million in cash and excluding ELITech’s clinical chemistry business, marks a […]